Muggers And Con Men

AUTHOR: PATRICK H. CLEVELAND, p.12 In his letter to The Scientist (February 22, 1993, page 10), Martin L. Stephens, vice president of the Humane Society of the United States (HSUS), took exception to my lumping his organization in with other animal rights groups ("Animal Rights Activism: Enough is Enough," The Scientist, Nov. 23, 1992, page 12). However, Stephens's artful use of language does not alter the fact that HSUS is indeed part of the same animal rights movement as People for the Ethical

Written byPatrick Cleveland
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

AUTHOR: PATRICK H. CLEVELAND, p.12

In his letter to The Scientist (February 22, 1993, page 10), Martin L. Stephens, vice president of the Humane Society of the United States (HSUS), took exception to my lumping his organization in with other animal rights groups ("Animal Rights Activism: Enough is Enough," The Scientist, Nov. 23, 1992, page 12). However, Stephens's artful use of language does not alter the fact that HSUS is indeed part of the same animal rights movement as People for the Ethical Treatment of Animals (PETA). HSUS was converted from animal welfare to animal rights by a membership vote at the group's 1980 annual meeting.

Clarifying HSUS's moral values and goals is important because many educators are unaware of its animal rights stance and educational programs, which attempt to redefine human moral value systems. Educators need to examine HSUS's own moral value system and determine whether it is brainwashing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies